SEC Form 4 · accession 0001140361-15-013040
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov Perlysky
Director
Period of report
Jan 1, 2015
Accepted (ET)
Mar 24, 2015 · 3:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jan 1, 2015 | J | 416,589 | — | D | 109,237 | I | By Grat |
| COMMON STOCKF1,F2 | Jan 1, 2015 | J | 1,923 | — | A | 1,923 | I | By Krovim |
| COMMON STOCKF1,F3 | Jan 1, 2015 | J | 3 | — | A | 3 | I | By Mid Atlantic |
| COMMON STOCKF1,F4 | Jan 1, 2015 | J | 40,872 | — | A | 40,872 | I | By Kinder Investment LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grat distributed to beneficiaries of the Grat for no consideration pro rata in accordance with its terms.
- F2Represents a 27.54% interest owned by children of Dov Perlysky.
- F3Represents Dov Perlysky .1% interest in the entity.
- F4Represents a 16.75% interest in the entity held by Dov Perlysky and wife's trust.